ACRP Announces TransCelerate's Intentions to Accept its Certification


Applied Clinical Trials

Clinical research professionals who have a current CPI or CCRC designation will be able to use that as evidence that retaking GCP training is not necessary if they are working on a trial for one of the TransCelerate companies.

The ACRP announced that TransCelerate BioPharma is accepting its affiliate’s certifications for Certified Clinical Research Coordinator (CCRC®) and Certified Physician Investigator (CPI®) as evidence of Good Clinical Practice (GCP) training.

That TransCelerate’s membership companies are accepting these certifications to eliminate redundant GCP training for each and every new study team the coordinators or investigators join is not a surprise. This initiative to create efficiencies in the clinical trials process was one of the original five targets set forth in TransCelerate’s formation. Specifically, at that time it said of Site Qualification and Training , its goal was “To build upon the creation of common criteria for mutual recognition of GCP training and common forms to collect generic information about study sites, TransCelerate will provide a common framework to streamline the process for qualifying investigator sites, and standardizing non-protocol specific forms for clinical trials. The organization will also establish criteria for training site personnel new to clinical research and trials.”

The ACRP affiliate--the Academy of Clinical Research Professionals (the Academy)--have produced more than 28,500 certificants in more than 60 countries since 1992 (including the CPI, CCRC, and Certified Clinical Research Associate [CCRA®] programs.

At posting time, TransCelerate had not yet posted its release or comments. You can read the ACRP's full release here.

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.